Bio-Techne (TECH) skyrocketed on June 25 after German science and technology company Merck KGaA (MKKGY) announced a ...

Merck KGaA has agreed to acquire Bio-Techne (NasdaqGS:TECH) for $11.5b in an all cash deal. Bio-Techne's board has ...

Germany’s Merck KGaA has announced a major acquisition agreement to buy U.S.-based life sciences company Bio-Techne Corp ...

Learn more Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) ...

Q1 beat and Bio-Techne deal drive upside, but valuation looks full. Read here for a detailed investment analysis.

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

Shares of U.S. life sciences company Bio-Techne jumped more than +22% in premarket trading on Thursday after Merck KGaA agreed to acquire the company for $73 per share in cash, va ...

Add Yahoo as a preferred source to see more of our stories on Google. Food supplement tablets placed around a Merck logo. Arne Dedert/dpa German science and technology major Merck KgaA reported on ...

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates, through a collaboration ...